Intracranial Stents Global Market Report 2024 by The Business Research Company | Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention

The intracranial stents market size has grown rapidly in recent years. It will grow from $0.42 billion in 2023 to $0.49 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increased awareness of stroke risks, improved patient education, rise in radiation safety measures, increased aging population, emergence of minimally invasive techniques.

The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $0.87 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of genomic medicine, rising healthcare infrastructure, expansion of stroke rehabilitation services, rising health initiatives. Major trends in the forecast period include adoption of bioresorbable intracranial stents, adoption of neurointerventional robotics, integration of advanced imaging technologies, adoption of pediatric intracranial stents, developing dual antiplatelet therapy strategies.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=5169&type=smp

Intracranial Stents Market Major Segments
The intracranial stents market covered in this report is segmented -

1) By Type: Self Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization
2) By Disease Indication: Brain Aneurysm, Intracranial Stenosis
3) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users

Key Driver - Rising Incidence Of Brain Aneurysms Boosts Growth In The Intracranial Stents Market

The increase in incidence of a brain aneurysm is expected to propel the growth of the intracranial stents market in the coming years. A brain aneurysm is the development of a bulge in the blood vessels of the brain. This bulge may rupture or burst and can cause brain haemorrhage, which may lead to the death of the patient. Intracranial vessel stenting (IVS) is a minimally invasive treatment for treating serious cerebral artery stenosis. The weakening of the arteries that deliver blood to the brain is known as cerebral artery stenosis. For instance, in February 2023, according to the Medical News Today, a UK-based medical news website, about 3.2% of persons worldwide have unruptured aneurysms. Thus, the increasing incidence of a brain aneurysm will drive the intracranial stents market growth.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=5169&type=smp

Prominent Trend - Innovative Onyx Frontier Drug-Eluting Stent Revolutionizes The Intracranial Stents Market

Major companies operating in the intracranial stents market are innovating new products such as Onyx Frontier drug-eluting stent (DES) to increase their profitability in the market. Onyx Frontier is a drug-eluting stent (DES) used to treat coronary artery disease (CAD), which is brought on by plaque accumulation inside the coronary arteries. For instance, in August 2022, Medtronic plc, an Ireland-based medical devices company launched Onyx Frontier drug-eluting stent (DES). The stent's architecture makes it ideal for sophisticated percutaneous cardiac intervention (PCI) and is highly deliverable. The Resolute Onyx DES's acute performance and clinical data provide the foundation for the Onyx Frontier DES, which provides a better delivery mechanism and greater acute performance.

Intracranial Stents Market Players
Major companies operating in the intracranial stents market include Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention Inc., Phenox GmbH, Terumo Corporation, Johnson & Johnson Services Inc., Abbott Laboratories, Brainlab AG, Cardiatis SA, Cook Medical LLC, DePuy Synthes, Endologix Inc., InspireMD Inc., Integra LifeSciences Corporation, Kaneka Corporation, Kerecis Limited, Penumbra Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Codman Neuro, C.R. Bard Inc., Cerebral Stents.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the intracranial stents market in 2023. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Intracranial Stents Market Report Structure
3. Intracranial Stents Market Trends And Strategies
4. Intracranial Stents Market - Macro Economic Scenario
5. Intracranial Stents Market Size And Growth
…..
27. Intracranial Stents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.